Vimarsana
Biggest News Aggregation in the World

John Lunger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Lunger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Lunger Today - Breaking & Trending Today

Adaptimmune Therapeutics : Transcript Q1 2024 - Vimarsana News

Adaptimmune Therapeutics : Transcript Q1 2024

Adaptimmune Q1 2024 Financial and Business Update Wednesday, May 15, 2024 - 8:00 AM ET C O R P O R A T E P A R T I C...

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q1 2024 Earnings Call Transcript - Vimarsana News

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q1 2024 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the Adaptimmune Q1 2024 Financial and Business Update Conference Call. I would now like to turn the meeting over to Ms. Juli Miller.

Adaptimmune Therapeutics plc (ADAP) Q3 2021 Earnings Call Transcript - Vimarsana News

Adaptimmune Therapeutics plc (ADAP) Q3 2021 Earnings Call Transcript

ADAP earnings call for the period ending September 30, 2021.

Source: fool.com
Solving Contract Manufacturing Shortages by Going In-House - Vimarsana News

Solving Contract Manufacturing Shortages by Going In-House

Solving Contract Manufacturing Shortages by Going In-House May 4, 2021 In 2017, Adaptimmune opened its U.S. headquarters at the Philadelphia Navy Yard after the company outgrew its space at the University City Science Center where it had been operating since 2011. [Adaptimmune] Share Officials at Adaptimmune, which focuses on cell therapies targeting solid tumors, say the company has built in-house bioprocessing capabilities to avoid shortages in outsourcing capacity for cell and gene therapies when they started manufacturing autologous therapies four to five years ago. “The CDMO market is ...